Renal Insufficiency
240
13
15
160
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
36 trials with published results (15%)
Research Maturity
160 completed trials (67% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.7%
16 terminated out of 240 trials
90.9%
+4.4% vs benchmark
19%
45 trials in Phase 3/4
23%
36 of 160 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 160 completed trials
Clinical Trials (240)
A Phase 1, Parallel, Single-Dose, Open-Label, Single-Period Study of LY3502970 in Participants With Normal Renal Function and Participants With Renal Impairment.
Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures, Third Wave
Product Surveillance Registry
HOLT-ED: Holter-monitoring in End-stage Renal Disease
Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD
A Study of Pharmacokinetics and Safety of LY3537031 in Participants With Normal Renal Function and Participants With Renal Impairment
A Study of LY3537982 in Participants With Kidney Problems Compared With Participants With Normal Kidney Function
Registry of Pre-mixed Solutions in Critically Ill Patients on the Continuous Renal Replacement Therapy
A Study to Test How Iclepertin is Taken up in the Blood of People With and Without Kidney Problems
A Study of the Effect of a Nurse Navigator Program on High Risk Patients
Effects of SGLT2 Inhibitors on Erythropoiesis in Heart Failure
A Study of Eloralintide (LY3841136) in Participants With Renal Impairment and in Participants With Normal Renal Function
A One Visit Follow Up of Adults With Fabry Disease Who Started Long-term Enzyme Replacement Therapy As Children
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
A Study of the Pharmacokinetics and Safety of Anaprazole Sodium in Special Populations
A Study to Determine Pharmacokinetic Changes of Ceftriaxone in Patients With Liver Cirrhosis
Food Frequency Questionnaire to Assess Sodium Intake
Safety, Tolerability and Pharmacokinetics of KBP-5074 in Healthy Subjects and Subjects With Renal Impairment
Concordance Between the Foot-to-Apex Systolic Interval and the Auscultatory Method for Measurement of Brachial Systolic Pressure in Patients With Severe Renal Failure
A Study to Test How BI 1015550 is Taken up in the Blood of People With and Without Kidney Problems